Plain-English translation of NCT06556407 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing renal denervation — a minimally invasive procedure where a catheter (thin tube) is used to block overactive nerves in your kidneys. The goal is to help lower blood pressure in people with kidney failure who are on hemodialysis and whose blood pressure remains dangerously high despite taking multiple blood pressure medications.
People with end-stage kidney disease on dialysis face a very high risk of heart attacks and strokes, often due to blood pressure that won't respond to standard medications. Research suggests that diseased kidneys send signals to the nervous system that make blood pressure rise uncontrollably, and blocking these nerve signals may help.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would undergo a renal denervation procedure performed by a specialist using a catheter inserted through blood vessels — similar to other heart catheterization procedures. The procedure would be done once, and you would then be monitored by the research team to see how well it works in controlling your blood pressure. The trial is very small (12 people total) and is currently recruiting participants.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Germany